232 related articles for article (PubMed ID: 31853668)
1. Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review.
Voizard N; Cerny M; Assad A; Billiard JS; Olivié D; Perreault P; Kielar A; Do RKG; Yokoo T; Sirlin CB; Tang A
Insights Imaging; 2019 Dec; 10(1):121. PubMed ID: 31853668
[TBL] [Abstract][Full Text] [Related]
2. Performance of LI-RADS version 2018 CT treatment response algorithm in tumor response evaluation and survival prediction of patients with single hepatocellular carcinoma after radiofrequency ablation.
Zhang Y; Wang J; Li H; Zheng T; Jiang H; Li M; Song B
Ann Transl Med; 2020 Mar; 8(6):388. PubMed ID: 32355832
[TBL] [Abstract][Full Text] [Related]
3. Post-treatment CT LI-RADS categories: predictors of overall survival in hepatocellular carcinoma post bland transarterial embolization.
Ormiston WEL; Yarmohammadi H; Lobaugh S; Schilsky J; Katz SS; LaGratta M; Velayati S; Zheng J; Capanu M; Do RKG
Abdom Radiol (NY); 2021 Aug; 46(8):3738-3747. PubMed ID: 32968863
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility of LI-RADS treatment response algorithm for hepatocellular carcinoma after locoregional therapy.
Abdel Razek AAK; El-Serougy LG; Saleh GA; Shabana W; Abd El-Wahab R
Diagn Interv Imaging; 2020 Sep; 101(9):547-553. PubMed ID: 32253141
[TBL] [Abstract][Full Text] [Related]
5. Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm.
Kielar A; Fowler KJ; Lewis S; Yaghmai V; Miller FH; Yarmohammadi H; Kim C; Chernyak V; Yokoo T; Meyer J; Newton I; Do RK
Abdom Radiol (NY); 2018 Jan; 43(1):218-230. PubMed ID: 28780679
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of Liver Imaging Reporting and Data System locoregional treatment response criteria: a systematic review and meta-analysis.
Gupta P; Bansal A; Das GC; Kumar-M P; Chaluvashetty SB; Bhujade H; Gulati A; Kalra N
Eur Radiol; 2021 Oct; 31(10):7725-7733. PubMed ID: 33786656
[TBL] [Abstract][Full Text] [Related]
7. Society of abdominal radiology survey of practice patterns in using LI-RADS treatment response criteria in the evaluation of hepatocellular carcinoma post-locoregional treatment.
Kampalath R; Mendiratta-Lala M; Lewis S; Benefield T; Yaghmai V; Burke L
Abdom Radiol (NY); 2023 Nov; 48(11):3401-3407. PubMed ID: 37658876
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Liver Imaging Reporting and Data System Treatment Response Criteria After Thermal Ablation for Hepatocellular Carcinoma.
Cools KS; Moon AM; Burke LMB; McGinty KA; Strassle PD; Gerber DA
Liver Transpl; 2020 Feb; 26(2):203-214. PubMed ID: 31677319
[TBL] [Abstract][Full Text] [Related]
9. Imaging After Locoregional Therapy for Hepatocellular Carcinoma with Emphasis on LIRADS Treatment Response Assessment Criteria.
Bajaj G; Sundaram K; Jambhekar K; Ram R
Semin Ultrasound CT MR; 2021 Aug; 42(4):318-331. PubMed ID: 34130846
[TBL] [Abstract][Full Text] [Related]
10. Cirrhotic liver: What's that nodule? The LI-RADS approach.
Shah A; Tang A; Santillan C; Sirlin C
J Magn Reson Imaging; 2016 Feb; 43(2):281-94. PubMed ID: 25996905
[TBL] [Abstract][Full Text] [Related]
11. Per-patient Negative Predictive Value of the CT and MRI Liver Imaging Reporting and Data System Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma.
Hassan OT; Behr SC; Ohliger MA; Fowler KJ; Gill RM; Fidelman N; Mehta N; Choi HH
Radiology; 2023 Dec; 309(3):e222776. PubMed ID: 38112541
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
[TBL] [Abstract][Full Text] [Related]
13. LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents.
Santillan C; Fowler K; Kono Y; Chernyak V
Abdom Radiol (NY); 2018 Jan; 43(1):75-81. PubMed ID: 28828680
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.
van der Pol CB; Lim CS; Sirlin CB; McGrath TA; Salameh JP; Bashir MR; Tang A; Singal AG; Costa AF; Fowler K; McInnes MDF
Gastroenterology; 2019 Mar; 156(4):976-986. PubMed ID: 30445016
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3 cm.
Ronot M; Fouque O; Esvan M; Lebigot J; Aubé C; Vilgrain V
J Hepatol; 2018 Apr; 68(4):715-723. PubMed ID: 29274407
[TBL] [Abstract][Full Text] [Related]
16. Role of the radiologist at HCC multidisciplinary conference and use of the LR-TR algorithm for improving workflow.
Shenoy-Bhangle AS; Tsai LL; Masciocchi M; Arora SS; Kielar AZ
Abdom Radiol (NY); 2021 Aug; 46(8):3558-3564. PubMed ID: 33904990
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
Zhang T; Huang ZX; Wei Y; Jiang HY; Chen J; Liu XJ; Cao LK; Duan T; He XP; Xia CC; Song B
World J Gastroenterol; 2019 Feb; 25(5):622-631. PubMed ID: 30774276
[TBL] [Abstract][Full Text] [Related]
18. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
[TBL] [Abstract][Full Text] [Related]
20. A radiogenomic analysis of hepatocellular carcinoma: association between fractional allelic imbalance rate index and the liver imaging reporting and data system (LI-RADS) categories and features.
Furlan A; Almusa O; Yu RK; Sagreiya H; Borhani AA; Bae KT; Marsh JW
Br J Radiol; 2018 Jun; 91(1086):20170962. PubMed ID: 29565672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
